Particularly, in HNSCC, the enhanced expression of PD-L1 in the TME, not only on tumor cells but also in M2-macrophages, was associated with decreased levels of effector CD4+ and CD8+ cells [75]. The gene discussed is CD8A; the disease is neoplasm.